AL

AltruBio

3 known investors

altrubio.com ↗

AltruBio develops antibody-based therapeutics for immunological and inflammatory diseases, with clinical-stage candidates (ALTB-268 and ALTB-168) targeting conditions such as ulcerative colitis, psoriatic arthritis, psoriasis, and acute graft versus host disease. Its programs are in preclinical through Phase II development.

Investors · 3

AM

aMoonRa'anana

DE

Delos CapitalCambridge

RA

RA CapitalBoston